Mycodern Statistics

Total Valuation

Mycodern has a market cap or net worth of PLN 51.31 million. The enterprise value is 53.77 million.

Market Cap	51.31M
Enterprise Value	53.77M

Important Dates

The next confirmed earnings date is Monday, November 16, 2026.

Earnings Date	Nov 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Mycodern has 65.78 million shares outstanding.

Current Share Class	65.78M
Shares Outstanding	65.78M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	82.00%
Owned by Institutions (%)	n/a
Float	11.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.40
Debt / Equity	n/a
Debt / EBITDA	14.32
Debt / FCF	n/a
Interest Coverage	0.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	2.86%
Return on Invested Capital (ROIC)	205.92%
Return on Capital Employed (ROCE)	-38.39%
Weighted Average Cost of Capital (WACC)	-0.02%
Revenue Per Employee	-543
Profits Per Employee	-27,620
Employee Count	23
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-0.88
52-Week Price Change	n/a
50-Day Moving Average	0.99
200-Day Moving Average	1.63
Relative Strength Index (RSI)	31.87
Average Volume (20 Days)	997

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mycodern had revenue of PLN -12,500 and -635,262 in losses. Loss per share was -0.01.

Revenue	-12,500
Gross Profit	10,375
Operating Income	112,134
Pretax Income	-635,262
Net Income	-635,262
EBITDA	171,990
EBIT	112,134
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	2.46M
Net Cash	-2.46M
Net Cash Per Share	-0.04
Equity (Book Value)	-2.75M
Book Value Per Share	-0.04
Working Capital	-401,762

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11,402
Capital Expenditures	n/a
Depreciation & Amortization	59,856
Net Borrowing	10,875
Free Cash Flow	-11,402
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-897.07%
Pretax Margin	5,082.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mycodern does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.24%
FCF Yield	-0.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mycodern has an Altman Z-Score of -127.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-127.02
Piotroski F-Score	2